Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000905718-21-000830
Filing Date
2021-06-24
Accepted
2021-06-24 17:49:06
Documents
1
Period of Report
2021-06-19

Document Format Files

Seq Description Document Type Size
1 matinasbio_fm4jun192021.html 4  
1 matinasbio_fm4jun192021.xml 4 7995
  Complete submission text file 0000905718-21-000830.txt   9404
Mailing Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921
Business Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921 908-484-8805
Matinas BioPharma Holdings, Inc. (Issuer) CIK: 0001582554 (see all company filings)

EIN.: 463011414 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MATINAS BIOPHARMA HOLDINGS, INC. 1545 ROUTE 206, SUITE 302 BEDMINSTER NJ 07921
Business Address
Jabbour Jerome D (Reporting) CIK: 0001698838 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38022 | Film No.: 211043938